Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 75 out of 100. Risk factors

Topic: Health services, long-term care and technology

Of 8171 patients with late-life depression, 1443 (17.7 %) had TRLLD. Amongst those with severe, psychotic or recurrent depression the prevalence of TRLLD was 30.7 %, 31.4 % and 27.0 % respectively. Female sex, recurrent, severe, or psychotic depression and higher self-harm risk were associated with higher odds of TRLLD after adjustment for demographics (Adjusted Odds ratio (aOR): 1.36, 2.05, 2.34, 2.21 and 1.30 respectively). Older age, Black ethnicity, cognitive impairment and difficulties in activities of daily living were associated with a lower likelihood of TRLLD (aOR: 0.97, 0.65, 0.71 and 0.76 respectively). Several physical conditions examined were associated with increased odds for TRLLD, the strongest association was with hypertension (aOR: 2.20). This is the first large-scale study examining the socio-demographic data as well as psychiatric and physical comorbidities in TRLLD without known dementia. Prevention and management of multi-morbidity should be considered in primary or secondary prevention of treatment-resistant depression.

Key findings

Study details

How this study scored 75/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record left out, no data; Study design 7 of 12; Strength of evidence 3 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 3 of 4; Effect reported 3 of 3; Studied in people 3 of 3; Randomised / blinded 0 of 2; Times cited left out, no data; Citations per year left out, no data; Impact for its field and year left out, no data; Cited by studies here left out, no data; Still being cited left out, no data; Senior author's track record left out, no data; Institution's track record left out, no data; Multi-centre collaboration left out, no data; Indexed in PubMed 2 of 2; Free to read left out, no data. 42 of the 56 points it could be judged on, which is 75 of 100. Total 75 of 100.42 of the 56 points we could judge = 75 of 100

Published in a peer-reviewed journal, and it is a cohort study following people over time. Scored zero for randomised / blinded because the record does not state it. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record, multi-centre collaboration and free to read, so those were left out: it earned 42 of the 56 points we could judge it on, which is 75 out of 100.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Journal of affective disorders)
Journal's citation record — / 4 No journal record from OpenAlex — left out of this score
Study design 7 / 12 A cohort study following people over time
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 3 / 4 8,171 participants
Effect reported 3 / 3 Effect reported with a statistic (interval, p-value, ratio or similar)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited — / 7 No citation count (not found in OpenAlex) — left out of this score
Citations per year — / 5 No citation count or no year — left out of this score
Impact for its field and year — / 6 No field-weighted citation impact (OpenAlex has none yet) — left out of this score
Cited by studies here — / 6 Not yet checked against this library's citation graph — left out of this score
Still being cited — / 4 No yearly citation counts — left out of this score
Senior author's track record — / 4 Senior author's record not available — left out of this score
Institution's track record — / 3 No institution listed in OpenAlex — left out of this score
Multi-centre collaboration — / 3 Institutions not listed — left out of this score
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 40174785)
Free to read — / 2 Access not recorded — left out of this score
Points 42 / 56 Scored on 10 of 20 parts. We have no data for the rest, so they are left out: 42 of the 56 points we could judge it on is 75 out of 100.
Total 75 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 7 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.

APA 7th

Moyano, B. P., Orgeta, V., von Gunten, A., Vandel, P., Ma, R., Stewart, R., et al. (2025). Treatment-resistant late-life depression prevalence and clinical/sociodemographic correlates: An electronic health records study. Journal of affective disorders. https://doi.org/10.1016/j.jad.2025.03.169

Vancouver

Moyano BP, Orgeta V, von Gunten A, Vandel P, Ma R, Stewart R, et al. Treatment-resistant late-life depression prevalence and clinical/sociodemographic correlates: An electronic health records study. Journal of affective disorders. 2025. doi:10.1016/j.jad.2025.03.169. PMID: 40174785.

BibTeX

@article{moyano2025-40174785,
  author  = {Moyano, Beatriz Pozuelo and Orgeta, Vasiliki and von Gunten, Armin and Vandel, Pierre and Ma, Ruimin and Stewart, Robert and Mueller, Christoph},
  title   = {{Treatment-resistant late-life depression prevalence and clinical/sociodemographic correlates: An electronic health records study}},
  journal = {Journal of affective disorders},
  year    = {2025},
  doi     = {10.1016/j.jad.2025.03.169},
  pmid    = {40174785},
  url     = {https://doi.org/10.1016/j.jad.2025.03.169}
}

Related studies in Risk factors

Similar studies

More on Risk factors

See all studies in Risk factors →